Home Weight loss (GLP-1) By state Vermont
Blue Cross VT's 2026 GLP-1 Exclusion: 8 programs ship to VT
Vermont's two big commercial insurers both dropped weight-loss GLP-1s on January 1, 2026. Blue Cross VT excluded Wegovy, Zepbound and Saxenda on exchange plans, many employer plans and the plans for school staff, and MVP Health Care discontinued the same coverage. Vermont Medicaid excludes weight-loss drugs by rule. Here is what each one still pays for, and what Vermonters do instead. The lowest price we found from a program that ships to Vermont: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.
Vermont at a glance
- Vermont Medicaid
- Does not cover for weight loss
- State employee plan
- Not published
- Adults with obesity
- 29.1% (2025)
- Programs we compare that ship to VT
- 8 of 22
Online GLP-1 programs for Vermont, cheapest first
Programs that ship to Vermont. Prescribed online by a licensed clinician; medication and delivery included.
How we pick and check programs
Our pick for November 2026

A daily oral GLP-1 plan. No needles, no injections
Compounded semaglutide in Vermont: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $89/mo 12-month plan | $99 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
| 3 | Refills | $99/mo | $99 / 4 wks | VisitRefills |
| 4 | Direct Meds | $297/mo | $297/mo | VisitDirect Meds |
| 5 | Gala | From $69/mo starting price, plan length not stated | Not stated | VisitGala |
| 6 | TrimRx | From $349/mo starting price, plan length not stated | Not stated | VisitTrimRx |
Compounded tirzepatide in Vermont: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | MaximusCheapest | $99.99/mo 12-month plan | Not offered | VisitMaximus |
| 2 | Lttl | $139/mo 12-month plan | $149 / 4 wks | VisitLttl |
| 3 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
| 4 | Refills | $159/mo | $159 / 4 wks | VisitRefills |
| 5 | Direct Meds | $399/mo | $399/mo | VisitDirect Meds |
| 6 | Gala | From $99/mo starting price, plan length not stated | Not stated | VisitGala |
| 7 | TrimRx | From $279/mo starting price, plan length not stated | Not stated | VisitTrimRx |
- Low month-to-month#1
Up to $140 off your first monthCompounded semaglutide for $99, month to month
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Pills or shots#2
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review - No contract#3
Fall sale: 40% offCompounded semaglutide as low as $99 a month
Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale4.2 on Trustpilot1,779 reviews ·Visit Refills Read our Refills review - Low-cost tirzepatide#4
Same price at every doseCompounded tirzepatide from $99.99 a month
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Delivery in 1-2 days#5
Fall sale: $150 offSame price at every dose, at your door in 1-2 days
Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"4.5 on Trustpilot17,724 reviews ·Visit Direct Meds Read our Direct Meds review
3 more programs are in the price tables above.
Blue Cross VT's 2026 exclusion, and who it reaches
The change covers members on Qualified Health Plans sold through Vermont Health Connect, Blue Edge Business plans, and plans for school employees through the Vermont Education Health Initiative. For them, GLP-1 drugs approved for weight loss became a benefit exclusion. Members who keep taking them after January 1, 2026 pay the full cost. Blue Cross VT told providers in its October 2025 newsletter, and affected members were notified by mail in the fall of 2025.
Some coverage remains. GLP-1s stay covered, with prior approval, for type 2 diabetes. Wegovy also stays covered for adults with heart disease and obesity when it's used to lower the risk of heart attack and stroke. Large fully insured employers and Blue Edge Classic clients can choose to keep weight-loss coverage. Blue Cross VT said the drugs' cost raises premiums for every member.
Vermont Medicaid doesn't cover GLP-1s for obesity either, according to KFF. So most Vermonters who want treatment for weight pay cash. Online programs fit a rural state well: you have a video or online visit, and the medication ships to your home, whether that's Burlington or the Northeast Kingdom. Several programs include shipping in the monthly price, and some keep that price the same as the dose goes up.
- Beginning January 1, 2026, Blue Cross VT no longer covers GLP-1 drugs FDA-approved for weight loss, such as Wegovy, Zepbound and Saxenda, for Qualified Health Plan, Blue Edge Business and VEHI members. (bluecrossvt.org)
- Blue Cross VT still covers GLP-1s with prior approval for type 2 diabetes, and Wegovy for adults with established cardiovascular disease and obesity to lower the risk of major cardiac events. (bluecrossvt.org)
- Blue Cross VT's August 2025 broker bulletin told employer groups they could choose to keep GLP-1 weight-loss coverage. (bluecrossvt.org)
- KFF's January 2026 review lists Vermont Medicaid as not covering GLP-1s for obesity. (kff.org)
- Vermont's adult obesity rate was 29.1% in 2025, sixth lowest among the states with a 2025 estimate. (cdc.gov)
- Vermont Medicaid's preferred drug list (updated April 17, 2026) states that drugs used for weight loss are excluded from coverage under the Vermont Medicaid Pharmacy program. (dvha.vermont.gov)
- Vermont Medicaid approves Wegovy for MACE reduction only with a BMI over 27, a history of stroke, heart attack or symptomatic peripheral arterial disease, no diabetes diagnosis and weight-management counseling; initial approval is six months. (dvha.vermont.gov)
- Vermont Medicaid covers Zepbound for obstructive sleep apnea with an AHI over 15, a BMI over 30 and prescribed CPAP; renewal requires more than 5% weight loss from baseline or keeping off the initial 5%. (dvha.vermont.gov)
- The Green Mountain Care Board found that MVP's discontinuation of weight-loss GLP-1 coverage in plan year 2026 lowers its 2026 rates by about 1.5% (individual) and 1.6% (small group). (gmcboard.vermont.gov)
Vermont Medicaid's drug list, read closely
Vermont Medicaid's preferred drug list, updated April 17, 2026, says it plainly: drugs used for weight loss are excluded from coverage under the Vermont Medicaid pharmacy program. GLP-1s still show up in two places. Wegovy injection is the preferred product in a cardiometabolic class, limited to four pens every 28 days, and the Wegovy tablet is non-preferred.
To get Wegovy approved for heart-risk reduction, the patient needs a BMI over 27 and a history of stroke, heart attack or symptomatic peripheral arterial disease. The drug can't be used for weight loss only, the patient can't have a diabetes diagnosis, and they must have had counseling on diet and activity. The first approval lasts six months, and the tablet requires a failed trial of the injection first. Wegovy for the liver disease MASH is a separate path, limited to the injection.
Zepbound for sleep apnea: Vermont Medicaid's checklist
Zepbound is the preferred drug in Vermont Medicaid's obstructive sleep apnea class, but only after clinical criteria are met. A sleep study has to show more than 15 breathing events an hour, the BMI must be over 30, CPAP must already have been prescribed, and the patient must have had weight-management counseling. People with type 2 diabetes, class IV heart failure, or a serious cardiac event in the last three months don't qualify.
Approval runs six months at a time. To renew, the patient has to keep following the diet and activity plan and show weight loss of more than 5% of baseline, or keep off the first 5%.
MVP's exit, and what it did to premiums
MVP Health Care, Vermont's other major insurer, also stopped covering weight-loss GLP-1s in 2026. The Green Mountain Care Board, which reviews and approves rates for individual and small group plans, found that this change lowers MVP's 2026 premiums by about 1.5% in the individual market and 1.6% in the small group market, and ordered MVP to build that into its rates. Blue Cross VT cited the same premium pressure for its exclusion.
Vermont's adult obesity rate, 29.1% in 2025, is the sixth lowest among the states with a 2025 estimate. Among adults 40 to 59 it was 35.5%. Lower rates haven't meant easier access. With commercial plans, school plans and Medicaid all closed for weight alone, Vermonters who want a GLP-1 for weight compare cash prices, and mail delivery reaches St. Johnsbury as easily as South Burlington.
GLP-1 in Vermont: questions
Does Blue Cross VT cover Wegovy or Zepbound for weight loss in 2026?
Not on most plans. Since January 1, 2026, Blue Cross VT excludes GLP-1 drugs approved for weight loss on Qualified Health Plans, Blue Edge Business and VEHI plans. Some large employers chose to keep coverage, so check with HR. If your plan excludes it, the online programs on this page offer GLP-1 care at one monthly cash price.
I'm a Vermont teacher on a VEHI plan. Is my GLP-1 still covered?
Only for certain uses. VEHI plans are part of Blue Cross VT's 2026 exclusion for weight-loss GLP-1s. They stay covered, with prior approval, for type 2 diabetes, and Wegovy stays covered for heart-risk reduction in adults with heart disease. If you're using a GLP-1 for weight alone, compare the cash programs above.
Why did Blue Cross VT drop GLP-1 weight-loss coverage?
Blue Cross VT says the drugs are costly and that the cost affects premiums for all members. It also notes that lasting weight loss needs long-term use, while many people stop after a few months. The result is that most Vermonters who want these drugs for weight now pay cash through an online program.
Does Vermont Medicaid cover GLP-1s for obesity?
No. Vermont Medicaid's drug list says drugs used for weight loss are excluded from its pharmacy program. GLP-1s for type 2 diabetes are a separate benefit with their own approvals, and Wegovy and Zepbound can be approved only for specific heart, liver or sleep apnea criteria. If you're on Green Mountain Care and want a GLP-1 for weight, the online programs compared on this page are the usual route.
Can my Vermont employer still choose to cover GLP-1s?
Some can. Blue Cross VT lets large employers on fully insured plans and Blue Edge Classic clients keep weight-loss GLP-1 coverage, and self-funded groups can choose it too. Qualified Health Plan and Blue Edge Business members can't. Ask your benefits contact what your group picked. If the answer is no, compare the programs above.
Does MVP Health Care cover Wegovy for weight loss in Vermont?
Not on its individual and small group plans in 2026. MVP discontinued coverage of weight-loss GLP-1 drugs for plan year 2026, and the Green Mountain Care Board lowered MVP's rates to reflect it. Coverage for type 2 diabetes is a separate matter. If you're an MVP member who wants a GLP-1 for weight, compare the cash programs on this page.
Does Vermont Medicaid cover Zepbound for sleep apnea?
Yes, if you meet its checklist. You need a sleep study showing more than 15 events an hour, a BMI over 30, a CPAP prescription and weight-management counseling, and you can't have type 2 diabetes. Approval lasts six months, and renewal needs more than 5% weight loss or keeping off the first 5%. Weight loss alone isn't covered.
What is the cheapest GLP-1 in Vermont?
Compounded semaglutide from $89 a month at Lttl, which ships to Vermont. Tirzepatide starts at $99.99 a month.
Can I get a GLP-1 prescribed online in Vermont?
Yes. The programs above say on their own sites that they serve Vermont.